Superbio

company

About

Superbio is a forensic and third-party medical testing service provider.

  • 1001 - 5000

Details

Last Funding Type
Series B
Industries
Biotechnology
Founded date
Aug 1, 2011
Number Of Employee
1001 - 5000
Operating Status
Active

Subo Medicine is a forensic and third-party medical testing service provider. Focus on providing users with judicial testing, medical testing and related services. It has four technology platforms: biochip technology platform, automated instrument technology platform, bioinformatics platform, genetic engineering technology platform, and based on professional identification methods and appraisal qualifications, it can also provide paternity test, forensic pathology identification and forensic clinical appraisal for users. And other business.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥50M
Superbio has raised a total of ¥50M in funding over 2 rounds. Their latest funding was raised on Mar 20, 2019 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 20, 2019 Series C ¥50M 1 Zero2IPO Capital Detail
Jan 1, 2017 Series B 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Superbio is funded by 1 investors. Zero2IPO Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Zero2IPO Capital Yes Series C